PRME — Prime Medicine Share News
0.000.00%
Last trade - 00:00- $676.54m
- $581.46m
- $4.63m
Prime Medicine, Inc. reports results for the quarter ended June 30 - Earnings Summary
Prime Medicine Q2 net loss narrows on lower expenses
Brief: Prime Medicine, Inc. Q2 EPS USD -0.24
Brief: Prime Medicine Announces U.S. FDA Clearance Of Investigational New Drug Application For Pm577a In H1069q-Mutated Wilson Disease
Prime Medicine Q1 net loss narrows as R&D expenses fall
Brief: Prime Medicine, Inc. Q1 EPS USD -0.28
Prime Medicine 2025 net loss widens, hurt by higher R&D expenses
Brief: Prime Medicine, Inc. FY EPS USD -1.35
Prime Medicine Q3 net loss narrows
Brief: Prime Medicine, Inc. Q3 EPS USD -0.32
Brief: Prime Medicine, Inc. Q2 Operating Expenses USD 54.492 Million
U.S. STOCKS ON THE MOVE-Apple, Palo Alto Networks, Xcel Energy
U.S. STOCKS ON THE MOVE-Microsoft, CoreWeave, Bristol Myers
U.S. STOCKS ON THE MOVE-Comcast, EBay, AbbVie
U.S. STOCKS ON THE MOVE-Biogen, Carvana, Cigna
Prime Medicine drops on $125 mln equity raise
Brief: Prime Medicine Prices Public Offering At $3.30 Per Share
Brief: Prime Medicine Announces Proposed Public Offering Of Common Stock
Prime Medicine falls on stock offering launch